Who We Are and What We Do

InFACT is a global collaboration of clinicians and researchers working in intensive care units around the world. We are committed to improving the care of patients with severe H1N1 infection through high quality clinical research into its natural history and optimal treatment.

InFACT has launched a comprehensive research program consisting of a global clinical registry, clinical trials of widely available and inexpensive interventions that might minimize the sequelae of severe H1N1 infection, a biobank to characterize genetic risk factors and the clinical biology of severe infection, and an initiative to attenuate severe H1N1 disease in the developing world where its toll will be greatest.

We are supported by a global network of investigator-led research groups, professional societies, and dedicated clinicians. We urge you to join us.

International H1N1 Clinical Registries

Click below to be connected to a registry in your region.

spacer
spacer
spacer
spacer
spacer

H1N1 Update

View Presentation:
H1N1 in ICUs located in Australia and New Zealand

As of January 31, 2010, worldwide more than 209 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 15,174 deaths.

spacer
Related searches:
infact clinical global severe overview
gipoco.com is neither affiliated with the authors of this page nor responsible for its contents. This is a safe-cache copy of the original web site.